Nighttime Protein Intake on Overnight Lipolysis and Morning Fat Oxidation in Obese Men
NCT ID: NCT02211391
Last Updated: 2015-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2014-07-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that carbohydrate intake will blunt the overnight lipolysis rate compared to casein protein and a non-caloric placebo. The investigators also hypothesize that casein and placebo will not be significantly different from each other in terms of overnight lipolysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Protein Timing and Resistance Exercise on Fat Metabolism
NCT03573687
Nighttime Macronutrient Choice and Combined Resistance and High-intensity Interval Training
NCT01830946
Effects of Calorie Restriction on Accumulation of Old, Modified Proteins in Abdominally Obese Adults
NCT01497106
Metabolic and Appetite Responses to a Whey Protein Preload Following Prior Exercise in Overweight Males
NCT02714309
Resistance Exercise and Protein During Weight Loss
NCT03600311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Casein Protein
Casein protein (30g) will be consumed as the last food/caloric beverage and within 30 minute of sleep
Casein Protein
The effect of casein protein consumed within 30 minutes of sleep on overnight lipolysis and next morning metabolism and appetite will be examined
Non-caloric Placebo
The non-caloric placebo beverage will will be consumed as the last food/caloric beverage and within 30 minute of sleep
Non-caloric placebo
The effect of a non-caloric placebo consumed within 30 minutes of sleep on overnight lipolysis and next morning metabolism and appetite will be examined
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Casein Protein
The effect of casein protein consumed within 30 minutes of sleep on overnight lipolysis and next morning metabolism and appetite will be examined
Non-caloric placebo
The effect of a non-caloric placebo consumed within 30 minutes of sleep on overnight lipolysis and next morning metabolism and appetite will be examined
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Florida State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael J. Ormsbee
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Ormsbee, PhD
Role: PRINCIPAL_INVESTIGATOR
Florida State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Sports Science and Medicine, Florida State University
Tallahassee, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC# 2014.13509
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.